Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on December 10, 2022 , the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 124,100 shares of its common stock to 11 new employees,

View Full Press Release